May 27, 2016
Recommended Topic Related To:

Juxtapid

"The U.S. Food and Drug Administration today approved Repatha (evolocumab) injection for some patients who are unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options.

Repatha, the second dr"...

A A A

Juxtapid




PATIENT INFORMATION

No information provided. Please refer to the WARNINGS AND PRECAUTIONS sections.

Last reviewed on RxList: 3/25/2016
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Cholesterol Management

Tips to keep it under control.